🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 21 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 11/01/2005 | 38,93 | 38,93 | 36,91 | 36,94 | -3,42% | 5,19% | 365.057 |
| 10/01/2005 | 38,18 | 42,26 | 37,95 | 38,25 | +0,10% | 11,27% | 540.932 |
| 07/01/2005 | 39,86 | 39,94 | 38,14 | 38,22 | -3,68% | 4,51% | 218.943 |
| 06/01/2005 | 39,64 | 40,61 | 39,15 | 39,68 | +0,57% | 3,68% | 209.031 |
| 05/01/2005 | 41,17 | 41,17 | 39,41 | 39,45 | -4,36% | 4,27% | 281.647 |
| 04/01/2005 | 42,56 | 42,74 | 40,31 | 41,25 | -1,61% | 5,72% | 299.547 |
| 03/01/2005 | 43,91 | 44,50 | 41,17 | 41,92 | -3,78% | 7,59% | 267.247 |
| 31/12/2004 | 44,17 | 44,17 | 43,01 | 43,57 | -0,77% | 2,63% | 169.998 |
| 30/12/2004 | 43,57 | 44,17 | 43,08 | 43,91 | +0,17% | 2,49% | 171.548 |
| 29/12/2004 | 44,88 | 44,92 | 43,72 | 43,83 | -1,35% | 2,67% | 146.728 |
| 28/12/2004 | 44,24 | 44,43 | 41,70 | 44,43 | -0,17% | 6,18% | 341.626 |
| 27/12/2004 | 44,80 | 45,10 | 43,98 | 44,50 | -0,50% | 2,51% | 169.437 |
| 23/12/2004 | 44,69 | 44,95 | 44,54 | 44,73 | -0,50% | 0,92% | 467.168 |
| 22/12/2004 | 45,63 | 48,55 | 44,47 | 44,95 | -1,48% | 8,94% | 608.472 |
| 21/12/2004 | 44,28 | 45,70 | 44,28 | 45,63 | +2,87% | 3,21% | 151.938 |
| 20/12/2004 | 45,03 | 45,93 | 43,98 | 44,35 | -1,66% | 4,32% | 278.201 |
| 17/12/2004 | 45,63 | 46,08 | 44,73 | 45,10 | -1,15% | 2,95% | 188.246 |
| 16/12/2004 | 47,09 | 47,35 | 45,55 | 45,63 | -3,48% | 3,82% | 155.438 |
| 15/12/2004 | 46,49 | 47,50 | 46,15 | 47,27 | +1,61% | 2,90% | 257.575 |
| 14/12/2004 | 46,00 | 46,71 | 45,51 | 46,53 | +1,22% | 2,60% | 261.823 |
| 13/12/2004 | 44,50 | 45,96 | 43,79 | 45,96 | +4,96% | 4,88% | 288.353 |
| 10/12/2004 | 43,53 | 44,54 | 42,60 | 43,79 | -0,17% | 4,47% | 224.286 |
| 09/12/2004 | 43,42 | 44,62 | 42,37 | 43,87 | -0,34% | 5,17% | 382.048 |
| 08/12/2004 | 42,71 | 44,02 | 42,00 | 44,02 | +3,16% | 4,73% | 498.212 |
| 07/12/2004 | 44,54 | 44,58 | 41,73 | 42,67 | -4,52% | 6,39% | 336.951 |
| 06/12/2004 | 44,65 | 44,95 | 43,98 | 44,69 | +0,42% | 2,18% | 1.304.094 |
| 03/12/2004 | 43,34 | 44,88 | 43,08 | 44,50 | +2,06% | 4,15% | 637.219 |
| 02/12/2004 | 43,76 | 44,20 | 42,89 | 43,61 | -1,52% | 2,99% | 362.545 |
| 01/12/2004 | 41,92 | 44,50 | 41,70 | 44,28 | +5,63% | 6,70% | 500.243 |
| 30/11/2004 | 41,62 | 42,07 | 41,14 | 41,92 | +0,36% | 2,25% | 241.519 |